PENJARLA, Srishylam, Paidi Yella REDDY, Santhosh PENTA, Yogesh S. SANGHVI, Ludek EYER, Michal STEFANIK, Daniel RŮŽEK and Shyamapada BANERJEE. Efficient synthesis of novel 2-deoxy-C-nucleosides containing oxa and thiadiazole derivatives and their biological activity. Journal of Molecular Structure. Amsterdam: Elsevier, 2023, vol. 1292, November 2023, p. 1-19. ISSN 0022-2860. Available from: https://dx.doi.org/10.1016/j.molstruc.2023.136099.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Efficient synthesis of novel 2-deoxy-C-nucleosides containing oxa and thiadiazole derivatives and their biological activity
Authors PENJARLA, Srishylam, Paidi Yella REDDY, Santhosh PENTA, Yogesh S. SANGHVI, Ludek EYER, Michal STEFANIK, Daniel RŮŽEK (203 Czech Republic, belonging to the institution) and Shyamapada BANERJEE (guarantor).
Edition Journal of Molecular Structure, Amsterdam, Elsevier, 2023, 0022-2860.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10606 Microbiology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.800 in 2022
RIV identification code RIV/00216224:14310/23:00132638
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.molstruc.2023.136099
UT WoS 001032754800001
Keywords in English C -nucleoside; Oxadiazoles; Thiadiazoles; Antiviral; Antitumor; Heterocycles
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 22/12/2023 09:16.
Abstract
Five membered oxa- and thiadiazole derivatives have shown significant biological activity due to their unique bioisosteric properties. Herein, we describe an efficient synthetic approach leading to several novel C-nucleosides containing an oxadiazole or thiadiazole ring system. This work provides for the first-time ability to assemble & beta;-Cnucleosides in a facile manner offering an ideal framework for the possible development of new antiviral and antitumor drugs. All new C-nucleosides were tested for their activity against TBEV and SARS-CoV-2. Two of the synthesized compounds exerted mild anti-SARS-CoV-2 activity, as evidenced by the decrease in viral titers by <1 log10 PFU/ml compared with controls. Mechanism for the formation of 5-substituted 1,3,4-thiadiazole ring is proposed and a structure-activity relationship established with these C-nucleosides.
PrintDisplayed: 21/7/2024 04:41